首页> 外文期刊>Acta Anaesthesiologica Scandinavica >Effects of fibrinogen and platelet transfusion on coagulation and platelet function in bleeding cardiac surgery patients
【24h】

Effects of fibrinogen and platelet transfusion on coagulation and platelet function in bleeding cardiac surgery patients

机译:纤维蛋白原输血对出血心脏手术患者凝血和血小板功能的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background Excessive bleeding is a significant problem in cardiac surgery. Fibrinogen and platelet concentrate transfusion are used clinically to improve haemostasis and reduce bleeding but little is known about their functional effects on coagulation and platelet function in patients with ongoing bleeding. Methods Forty‐two patients with ongoing bleeding after cardiac surgery were included in an observational study. Patients received either fibrinogen concentrate (n?=?16), platelet concentrate (n?=?12), or both fibrinogen and platelets (n?=?14), median doses 2?g fibrinogen and 2 units platelets given at one occasion. Blood samples were collected before and after transfusion. Coagulation (clotting time and clot stability) was analysed with rotational thromboelastometry, and platelet function with impedance aggregometry. In addition, platelet count and fibrinogen concentration was measured. Chest drain output was measured before and after the transfusion. Results Fibrinogen infusion resulted in an increase in fibrinogen concentration and clot stability ( P ?=?0.001), but had no effect on platelet aggregation. Platelet transfusion did not significantly affect coagulation, but improved arachidonic acid‐ and TRAP‐induced platelet aggregation ( P ?=?0.017 and 0.034 respectively) and increased platelet count. Combined fibrinogen and platelet transfusion shortened clotting time ( P ?=?0.005) and increased clot stability ( P ?=?0.001), and improved arachidonic acid‐ and TRAP‐induced platelet aggregation ( P ?=?0.004 and 0.016 respectively), and increased fibrinogen concentration and platelet count. The median bleeding volume was 150 (25th‐75th percentile 70‐240)?mL/h before, and 60 (40‐110)?mL/h after transfusion of fibrinogen and/or platelet concentrate ( P ??0.001). Conclusion The results demonstrate improved coagulation and platelet function following fibrinogen and platelet transfusion in patients bleeding after cardiac surgery.
机译:背景,过度出血是心脏手术的一个重要问题。纤维蛋白原和血小板浓缩输血在临床上使用,以改善血糖和减少出血,但对持续出血患者的凝血和血小板功能的功能作用很少。方法包括心脏手术后持续出血的42例患者均包含在一个观察性研究中。患者接受纤维蛋白原浓缩物(n?=α16),血小板浓缩物(n?=Δ12),或纤维蛋白原和血小板(n?=Δ14),中值剂量2?g纤维蛋白原和2个单位血小板给出一次。在输血之前和之后收集血样。用旋转血栓弹性测定法分析凝血(凝结时间和凝块稳定性),具有阻抗聚体的血小板函数。此外,测量血小板计数和纤维蛋白原浓度。在输血之前和之后测量胸排水输出。结果纤维蛋白原输注导致纤维蛋白原浓度和凝块稳定性的增加(p?= 0.001),但对血小板聚集无效。血小板输血没有显着影响凝血,而是改善的血小板和捕集血小板聚集(P≤0.017和0.034)和增加的血小板计数。组合纤维蛋白原和血小板输血缩短了凝血时间(p?= 0.005)并提高凝块稳定性(p?= 0.001),并改善了捕获血小板聚集(P?= 0.004和0.016),和增加纤维蛋白原浓度和血小板计数。中位出血体积为150(25-75百分位数70-240)?ML / H之前,60(40-110)?输血后纤维蛋白原和/或血小板浓缩物(P 1 0.001)。结论结果表明,心脏手术后患者出血患者纤维蛋白原和血小板输血后改善的凝血和血小板功能。

著录项

  • 来源
  • 作者单位

    Department of Molecular and Clinical Medicine Institute of MedicineSahlgrenska Academy University;

    Department of Molecular and Clinical Medicine Institute of MedicineSahlgrenska Academy University;

    Department of Clinical Chemistry and Transfusion Medicine Institute of Biomedicine Sahlgrenska;

    Department of Molecular and Clinical Medicine Institute of MedicineSahlgrenska Academy University;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 麻醉学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号